BPC-157

Accelerating

BPC-157 appears in 234 indexed publications going back to 1992, including 36 in the past twelve months. 2 registered trials appear on ClinicalTrials.gov.

234
Indexed publications
36
Past 12 months, against 12 the year before
2
Registered clinical trials
22,422
Monthly readers on Wikipedia, down 4%
Research Activity

Publication history

How much work has been indexed each year, from Europe PMC. Momentum is measured over a trailing twelve months rather than calendar years, so a partial current year never reads as a decline.

20152026

Publications per year. The final bar is the current year, still in progress.

Indexed publications per year
20155
20168
201711
20189
20196
202011
202119
202212
202310
20245
202519
202627
Public Attention

Who is looking it up

Monthly readers of the BPC-157 article on English Wikipedia. An independent measure of curiosity, which often moves quite differently from the evidence.

2025-082026-07
Clinical Trials

The registered pipeline

Early Phase 1
0
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0

Phase distribution across the most recently updated registered trials.

References

Most recent work

The newest indexed records mentioning BPC-157, listed by publication date. Titles are shown as published and link to their source. Inclusion here is a record of what exists, not a judgement of what it shows.

  1. 2026-07-01·Current sports medicine reports

    Effects of Supplementation in Masters Athletes and Older Adults: A Narrative Review

    Nguyen C, Allen MR, Hornburg K et al.

  2. 2026-07-27·The Analyst

    Rapid and harmonized analytical workflow for the determination of peptidic and non-peptidic doping agents in dried and liquid blood matrices

    Mazzarino M, Colpaert T, Deventer K et al.

  3. 2026-06-01·Journal of physiology and pharmacology : an official journal of the Polish Physiological Society

    Stable pentadecapeptide therapy counteracts gentamicin-induced nephrotoxicity via nitric oxide-system modulation: evidence from a triple nitric oxide-agent approach in rats

    Vukoja I, Vlainic J, Francina M et al.

  4. 2026-05-30·Pharmaceuticals (Basel, Switzerland)

    Unilateral Adrenalectomy, and the Stable Pentadecapeptide BPC 157 as Therapy in Rats-A Cytoprotection Approach

    Smoday IM, Vukovic V, Oroz K et al.

  5. 2026-05-30·International journal of molecular sciences

    BPC-157 and Its Novel Hybrid Analogs as Inhibitors of Acetylcholinesterase

    Jelińska J, Józwiak M, Szeleszczuk Ł et al.

  6. 2026-05-28·Scientific reports

    Protective effects of BPC 157 in rats with experimentally induced lower extremity ischemia-reperfusion injury

    Yıldırım AK, Demirtaş H, Özer A et al.

  7. 2026-05-20·Pharmaceutics

    BPC-157 as an Investigational Peptide Therapeutic: Biopharmaceutical Challenges, Formulation Strategies, and Translational Development Barriers

    Mateescu DM, Gavrilescu DM, Constantinescu FE et al.

  8. 2026-05-20·JBJS reviews

    Injectable Peptides in Sports Medicine: A Structured Narrative Review of Evidence, Safety, and Antidoping Implications

    Villegas Meza AD, Nocek M, Mitchell BC et al.

In the Catalogue

BPC-157 available from Polaris Research

Supplied as research materials for laboratory use. Free express delivery Australia wide.

Sources

Publication data from Europe PMC. Clinical trial data from ClinicalTrials.gov, U.S. National Library of Medicine. Public attention from Wikimedia pageview data. Evidence grades from reptides.co. We report counts and dates from these sources and link every record to its origin, we do not summarise findings. Last synced 2026-08-02.